Recent Updates
Recently added Catalysts

Tissue Repair Cells

Phase 1

Alveolar Bone Loss | Monoclonal antibody | Musculoskeletal |Vericel Corporation|Last Updated: Jul 3, 2015

Success Probability
Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
Premium
Market & Valuation
rNPV $3.2B
Market Size $9.4B
Revenue Basis $1.6B
Competitors 6
Premium
Trial Design
RandomizedSHAM_CONTROLLEDDMCBiomarker
Total Trials1
Total Enrollment24
FDA Designations
No designations recorded
Clinical Trials (1)
NCT IDTitlePhaseStatusEnrollmentVelocityDesignStartCompletionLast UpdatedSitesCountries
NCT00755911Treatment of Alveolar Bone Defects Using Aastrom Biosciences Autologous Tissue Repair Cell TherapyPHASE1 COMPLETED 24Jun 1, 2008May 1, 2012Jul 3, 20151 United States
Unlock Drug Trial Details
Study Endpoints
Primary Endpoints
Bone Regeneration
12 months after tooth extraction

The primary objective of this study is to determine whether the placement of Tissue Repair Cells (TRCs) at the time of tooth extraction can safely and effectively promote bone regeneration in alveolar bone defects created by tooth extraction. * Safety was assessed through adverse event reporting * Bone regeneration was assessed through measures of bone mineral density and bone volume fraction of biopsied regenerated bone tissue. Bone regeneration was also measured through radiographic analysis of relative bone height gain (% of the bone height regenerated relative to the height before tooth extraction)

Secondary Endpoints
Number of Participants Who Successfully Received Dental Implant Fixtures
12 months after tooth extraction
Unlock Study Endpoints
Study Design & Arms
AllocationRANDOMIZED
MaskingNONE
ModelPARALLEL
PurposeTREATMENT
Treatment Arms
ArmTypeDescription
Tissue Repair Cells (TRC)EXPERIMENTALSubjects will receive Tissue Repair Cell (TRC) therapy plus Gelfoam carrier
ControlSHAM_COMPARATORSubjects will receive the control treatment, consisting of Gelfoam carrier without Tissue Repair Cell (TRC) therapy.
Interventions
NameTypeDescription
Tissue Repair Cells (TRC)BIOLOGICAL30-50 ml of bone marrow is aspirated from subject and processed into TRC autologous bone marrow tissue graft. 10ml of TRC will be absorbed onto gelfoam carrier and placed in extraction socket.
ControlDEVICEControl subjects only receive standard gelfoam carrier. It promotes healing after tooth extraction
Unlock Study Design Details
Eligibility Criteria
Age Range20 Years — 70 Years
SexALL
Healthy VolunteersNo
Study Sites1

Inclusion Criteria: * Age range: 20 to 70 years * Gender: Male and female * Patients must be able and willing to follow study procedures and instructions * Patients must have read, understood and signed an informed consent form * Patients must require tooth extraction as a result of caries, periodo...

Countries:United States
Unlock Eligibility Criteria